The European Commission approved the use of Avastin with Gemzar and Carboplatin for treatment of the first recurrence of ovarian cancer.
See the article here
- Just Diagnosed?
- About Ovarian Cancer
- Resources
- Advocacy
- Get Involved
The European Commission approved the use of Avastin with Gemzar and Carboplatin for treatment of the first recurrence of ovarian cancer.
See the article here
All content © Copyright 2013 by Ovarian Cancer National Alliance.
Subscribe to our RSS Feed or view our Sitemap
Privacy Policy
This site made possible by a grant from Novartis Oncology
